Research Grant[Cite as http://purl.org/au-research/grants/nhmrc/1010405]
Researchers: Prof Elizabeth Rakoczy (Principal investigator) , Dr Chooi-May Lai , Dr Matthew Wikstrom , Prof Ian Constable
Brief description Age-related Macular Degeneration (AMD) is the major cause of blindness in the developed world. The present best practice for treating wet AMD is monthly injections of Lucentis� into the eye which is expensive, inconvenient for the patient and has increased risk of infection. The additional assays associated with the clinical trial will test whether adeno-associated virus-mediated gene therapy is safe and whether it can eliminate the need of multiple injections while delivering the same outcome.
Funding Amount $AUD 373,076.33
Funding Scheme NHMRC Project Grants
Notes Standard Project Grant
- PURL : http://purl.org/au-research/grants/nhmrc/1010405
- nhmrc : 1010405